Literature DB >> 20444505

HtrA, RseP, and Tsp proteins do not elicit a pathology-related serum IgG response during sexually transmitted infection with Chlamydia trachomatis.

Wilhelmina M Huston1, Charles W Armitage, Amba Lawrence, Sarina Gloeckl, Steven J Bell, Joseph Debattista, John A Allan, Peter Timms.   

Abstract

Chlamydia trachomatis sexually transmitted infection can cause serious reproductive morbidities. This study determined the prevalence of a serum IgG response to C. trachomatis putative stress response proteins in women, to test for an association with genital tract pathology. There was no significant association of serum IgG reactive with C. trachomatis HtrA, Tsp, or RseP with infection or pathology. cHSP60 serum IgG prevalence was significantly associated with infection compared to IgG negative infertile controls, but not with upper genital tract pathology. Serum IgG(1-4) antibody subclasses reactive with these antigens was not significantly different between cohorts, although different responses to each antigen were detected. Crown Copyright (c) 2010. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20444505     DOI: 10.1016/j.jri.2010.02.007

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  8 in total

1.  Antibody to Chlamydia trachomatis proteins, TroA and HtrA, as a biomarker for Chlamydia trachomatis infection.

Authors:  K Hokynar; S Korhonen; P Norja; J Paavonen; M Puolakkainen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-14       Impact factor: 3.267

2.  Proof of concept: A bioinformatic and serological screening method for identifying new peptide antigens for Chlamydia trachomatis related sequelae in women.

Authors:  Scott H Stansfield; Pooja Patel; Joseph Debattista; Charles W Armitage; Kelly Cunningham; Peter Timms; John Allan; Aruna Mittal; Wilhelmina M Huston
Journal:  Results Immunol       Date:  2013-05-13

Review 3.  What Can Serology Tell Us About the Burden of Infertility in Women Caused by Chlamydia?

Authors:  Patrick J Horner; Gloria E Anyalechi; William M Geisler
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 5.226

Review 4.  Immunity and vaccines against sexually transmitted Chlamydia trachomatis infection.

Authors:  Sarah E M Howie; Patrick J Horner; Andrew W Horne; Gary Entrican
Journal:  Curr Opin Infect Dis       Date:  2011-02       Impact factor: 4.915

5.  Production, secretion and purification of a correctly folded staphylococcal antigen in Lactococcus lactis.

Authors:  Frédéric Samazan; Bachra Rokbi; Delphine Seguin; Fabienne Telles; Valérie Gautier; Gilbert Richarme; Didier Chevret; Paloma Fernández Varela; Christophe Velours; Isabelle Poquet
Journal:  Microb Cell Fact       Date:  2015-07-16       Impact factor: 5.328

6.  A cohort study of Chlamydia trachomatis treatment failure in women: a study protocol.

Authors:  Jane S Hocking; Lenka A Vodstrcil; Wilhelmina M Huston; Peter Timms; Marcus Y Chen; Karen Worthington; Ruthy McIver; Sepehr N Tabrizi
Journal:  BMC Infect Dis       Date:  2013-08-17       Impact factor: 3.090

7.  Evaluation of a PGP3 ELISA for surveillance of the burden of Chlamydia infection in women from Australia and Samoa.

Authors:  Rami Mazraani; Peter Timms; Philip C Hill; Tamaailau Suaalii-Sauni; Tavita Niupulusu; Seiuli V A Temese; Liai Iosefa-Siitia; Leveti Auvaa; Siuomatautu A Tapelu; Maauga F Motu; Antoinette Righarts; Michael S Walsh; Luk Rombauts; John A Allan; Patrick Horner; Wilhelmina M Huston
Journal:  Pathog Dis       Date:  2019-04-01       Impact factor: 3.166

8.  The IL-6 response to Chlamydia from primary reproductive epithelial cells is highly variable and may be involved in differential susceptibility to the immunopathological consequences of chlamydial infection.

Authors:  Kelly Cunningham; Scott H Stansfield; Pooja Patel; Shruti Menon; Vivian Kienzle; John A Allan; Wilhelmina M Huston
Journal:  BMC Immunol       Date:  2013-11-15       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.